1,4-Di(2-thienyl)-1,3-butadiene (mixture of isomers)>97.0%(GC)1g

2',4'-Dihydro-1'H-spiro[piperidine-4,3'-quinoline]-2'-one hydrochloride, 95.0%, 100mg

Ethyl 3,4-diaminobenzoate, 95.0%, 25g

3-Bromo-4-(dimethylamino)benzaldehyde, 95.0%, 1g

tert-Butyl (3-(hydroxymethyl)-4,5,6,7-tetrahydrobenzo[d]isoxazol-5-yl)carbamate, 98%, 250mg

Tapón con vidrio hueco cónico estándar, 29/32, 10 Unidad(es)

N2-(1H-1,3-benzodiazol-6-yl)-N4-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine, 98%, 100mg

(R)-1-(2-Fluoro-4-methylphenyl)ethan-1-ol, 98%, 250mg

4-(Dimethylamino)-2-hydroxybenzoic acid, 95.0%, 250mg

[2-(ethylthio)-1,3-thiazol-4-yl]acetic acid, 95.0%, 1g

Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphate (3:1), 1g

Pyrazole-3-carboxamide, 98.0%, 5g

Methyl 2-N-Boc-2-aminomethyl-3-(4-chloro-phenyl)-propionate, 97.0%, 1g